AB
TERN

Amalgamated Bank’s Terns Pharmaceuticals TERN Stock Holding History

Amalgamated Bank’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,694
Closed -$109K – 2699
2025
Q4 		$109K Buy
2,694
+268
+11% +$6.19K ﹤0.01% 1690
2025
Q3 		$18K Hold
2,426
– – ﹤0.01% 2180
2025
Q2 		$9K Hold
2,426
– – ﹤0.01% 2507
2025
Q1 		$7K Buy
2,426
+981
+68% +$4.01K ﹤0.01% 2548
2024
Q4 		$8K Hold
1,445
– – ﹤0.01% 2570
2024
Q3 		$12K Hold
1,445
– – ﹤0.01% 2376
2024
Q2 		$10K Hold
1,445
– – ﹤0.01% 2468
2024
Q1 		$9K Sell
1,445
-3,830
-73% -$25K ﹤0.01% 2501
2023
Q4 		$34K Sell
5,275
-430
-8% -$2.27K ﹤0.01% 2412
2023
Q3 		$29K Hold
5,705
– – ﹤0.01% 2488
2023
Q2 		$50K Buy
+5,705
New +$66.5K ﹤0.01% 2326
2022
Q2 		– Sell
-2,079
Closed -$6K – 3195
2022
Q1 		$6K Buy
+2,079
New +$8.88K ﹤0.01% 3020

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Amalgamated Bank's TERN Position: Q1 2026 in Review

Amalgamated Bank sold out of Terns Pharmaceuticals (TERN) in Q1 2026, closing a stake of 2,694 shares — an estimated $109K sold.

Amalgamated Bank first reported a position in TERN in Q1 2022 and held it in 12 quarters. The position peaked at $109K in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Amalgamated Bank reported no remaining Terns Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,694 Terns Pharmaceuticals shares in Q1 2026, an estimated $109K.
  • Amalgamated Bank first reported a position in Terns Pharmaceuticals in Q1 2022 and held it in 12 quarters.
  • Amalgamated Bank's Terns Pharmaceuticals position peaked at $109K in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.